Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

RANI Rani Therapeutics Holdings Inc

Price (delayed)

$0.6406

Market cap

$36.86M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.99

Enterprise value

$52.42M

Highlights
The debt has declined by 28% year-on-year and by 14% since the previous quarter
The EPS has increased by 23% YoY and by 6% from the previous quarter
The company's equity has shrunk by 141% YoY
The quick ratio has dropped by 72% year-on-year and by 41% since the previous quarter

Key stats

What are the main financial stats of RANI
Market
Shares outstanding
57.54M
Market cap
$36.86M
Enterprise value
$52.42M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
17.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
43.68
Earnings
Revenue
$1.2M
Gross profit
$1.2M
Operating income
-$51.29M
Net income
-$29.8M
EBIT
-$25.12M
EBITDA
-$22.18M
Free cash flow
-$34.54M
Per share
EPS
-$0.99
EPS diluted
-$0.99
Free cash flow per share
-$1.03
Book value per share
-$0.05
Revenue per share
$0.04
TBVPS
$0.72
Balance sheet
Total assets
$24.13M
Total liabilities
$29.47M
Debt
$25.67M
Equity
-$3.06M
Working capital
-$2.35M
Liquidity
Debt to equity
-8.4
Current ratio
0.88
Quick ratio
0.82
Net debt/EBITDA
-0.7
Margins
EBITDA margin
-1,848.3%
Gross margin
100%
Net margin
-2,483.3%
Operating margin
-4,274.5%
Efficiency
Return on assets
-80.5%
Return on equity
-2,437%
Return on invested capital
-58.1%
Return on capital employed
-628.8%
Return on sales
-2,093.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

RANI stock price

How has the Rani Therapeutics Holdings stock price performed over time
Intraday
12.23%
1 week
-12.25%
1 month
-44.3%
1 year
-88.27%
YTD
-53.24%
QTD
-49.16%

Financial performance

How have Rani Therapeutics Holdings's revenue and profit performed over time
Revenue
$1.2M
Gross profit
$1.2M
Operating income
-$51.29M
Net income
-$29.8M
Gross margin
100%
Net margin
-2,483.3%
The operating income has grown by 19% YoY and by 3.8% from the previous quarter
The operating margin is up by 18% since the previous quarter
RANI's gross profit is up by 17% since the previous quarter
The revenue has grown by 17% from the previous quarter

Price vs fundamentals

How does RANI's price correlate with its fundamentals

Growth

What is Rani Therapeutics Holdings's growth rate over time

Valuation

What is Rani Therapeutics Holdings stock price valuation
P/E
N/A
P/B
N/A
P/S
17.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
43.68
The EPS has increased by 23% YoY and by 6% from the previous quarter
The company's equity has shrunk by 141% YoY
The revenue has grown by 17% from the previous quarter

Efficiency

How efficient is Rani Therapeutics Holdings business performance
RANI's ROIC has plunged by 73% YoY and by 29% from the previous quarter
The ROA has plunged by 61% YoY and by 19% from the previous quarter
The ROS has increased by 14% from the previous quarter

Dividends

What is RANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RANI.

Financial health

How did Rani Therapeutics Holdings financials performed over time
Rani Therapeutics Holdings's total assets is 18% less than its total liabilities
The quick ratio has dropped by 72% year-on-year and by 41% since the previous quarter
The current ratio has shrunk by 72% YoY and by 41% QoQ
The company's debt to equity has shrunk by 156% QoQ
The company's equity has shrunk by 141% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.